SEC Filing Details
Document Details
Form
Filing Date
May 20, 2024
Document Date
May 16, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.
Filer
ORBIMED ADVISORS LLC